Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
J Appl Lab Med. 2021 Sep 1;6(5):1338-1354. doi: 10.1093/jalm/jfab034.
The COVID-19 pandemic has made a devastating impact on global health and continues to challenge healthcare infrastructure and delivery. The clinical laboratories were no exception as they are responsible for diagnostic testing that dictates many clinical, infection control, and public health decisions. Information technology and laboratory management tools are critical assets for maintaining and adapting operations in response to crises. When utilized effectively, they promote the integration between the clinical laboratory specialties (e.g., chemistry, hematology, microbiology, and molecular pathology). During the COVID-19 pandemic, our systems and processes were strained due to high testing volumes, demand for rapid turnaround times, supply chain constraints, and constantly evolving testing algorithms and result interpretations as our knowledge of the virus and of diagnostics increased over time. In this report, we describe those challenges and subsequent adaptations made by each clinical laboratory section. We hope these details help to provide potential solutions and approaches for other hospitals facing COVID-19 surges or other future pandemics.
COVID-19 大流行对全球健康造成了毁灭性的影响,继续挑战着医疗保健基础设施和服务的提供。临床实验室也不例外,因为它们负责进行诊断检测,这些检测决定了许多临床、感染控制和公共卫生决策。信息技术和实验室管理工具是维持和适应危机应对运营的关键资产。当有效利用时,它们促进了临床实验室专业之间的整合(例如化学、血液学、微生物学和分子病理学)。在 COVID-19 大流行期间,由于检测量高、对快速周转时间的需求、供应链限制以及随着我们对病毒和诊断知识的不断增加而不断演变的检测算法和结果解释,我们的系统和流程面临压力。在本报告中,我们描述了每个临床实验室部门所面临的这些挑战和随后的调整。我们希望这些细节能够为其他面临 COVID-19 激增或其他未来大流行的医院提供潜在的解决方案和方法。